INSIGHTEC, INC.
DALLAS, TX

INSIGHTEC, INC., founded in Dallas, Texas, has been making waves since February 11, 2013. This company stands out in the realm of non-invasive medical technologies, having developed Exablate® 2000-the first FDA-approved MRI-guided focused ultrasound system for treating essential tremor. The system's groundbreaking design earned it a prestigious gold award, highlighting INSIGHTEC's commitment to innovation. The company has been lauded extensively, such as when it was featured on the World Medical Innovation Forum's 'Disruptive Dozen' list for merging transcranial MRI-guided focused ultrasound with microbubble technology. This allows for precise targeting in deep tissues without surgical incisions or radiation exposure. Notably, INSIGHTEC was also part of the Technology Pioneers 2008 cohort recognized by the World Economic Forum. In its early days, Red Herring celebrated INSIGHTEC's inventive spirit on their Europe 2007 list alongside future tech heavyweights like Google and eBay. Its contributions to medical advancements were further affirmed when Exablate® technology received Frost and Sullivan’s Technical Innovation Award in 2005. Moreover, the Wall Street Journal recognized its Exablate Neuro solution with a Technology Innovation Award Bronze Winner accolade. More than just offering MR-guided focused ultrasound platforms like Exablate®, INSIGHTEC provides comprehensive support to healthcare partners. This includes clinical and commercial assistance, maintenance services, and insightful marketing strategies. Dedicated experts guide facilities through personalized training until they achieve certification and can operate independently. Aligning with organizational objectives, tackling reimbursement challenges, and establishing effective business models are key areas where INSIGHTEC's proficient team excels. Jun (Jim) Tao, the Chief Commercial Officer with notable experience in companies like Constellium and GE, plays a pivotal role in driving strategic commercial success. Headquartered at 4851 LBJ Freeway in Dallas, Texas, and carrying FEI Number 39-1948614, INSIGHTEC was reinstated on October 10, 2016. With an upcoming annual report due for filing in 2025, this trailblazing company continues to stand out as a leader in the medical technology innovation landscape.